IL135345A0 - Human toll homologues - Google Patents
Human toll homologuesInfo
- Publication number
- IL135345A0 IL135345A0 IL13534598A IL13534598A IL135345A0 IL 135345 A0 IL135345 A0 IL 135345A0 IL 13534598 A IL13534598 A IL 13534598A IL 13534598 A IL13534598 A IL 13534598A IL 135345 A0 IL135345 A0 IL 135345A0
- Authority
- IL
- Israel
- Prior art keywords
- human toll
- pro286
- pro285
- pro358
- proteins
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2896—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against molecules with a "CD"-designation, not provided for elsewhere
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- Food Science & Technology (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Tropical Medicine & Parasitology (AREA)
- Toxicology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Cardiology (AREA)
- Genetics & Genomics (AREA)
- Heart & Thoracic Surgery (AREA)
- Public Health (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Hospice & Palliative Care (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Oncology (AREA)
- Veterinary Medicine (AREA)
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US6225097P | 1997-10-17 | 1997-10-17 | |
US6531197P | 1997-11-13 | 1997-11-13 | |
US8332298P | 1998-04-28 | 1998-04-28 | |
US10541398A | 1998-06-26 | 1998-06-26 | |
US9086398P | 1998-06-26 | 1998-06-26 | |
PCT/US1998/021141 WO1999020756A2 (fr) | 1997-10-17 | 1998-10-07 | Homologues toll humains |
Publications (1)
Publication Number | Publication Date |
---|---|
IL135345A0 true IL135345A0 (en) | 2001-05-20 |
Family
ID=27535565
Family Applications (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL13534598A IL135345A0 (en) | 1997-10-17 | 1998-10-07 | Human toll homologues |
IL135345A IL135345A (en) | 1997-10-17 | 2000-03-29 | Humane TOLL homologues |
IL180967A IL180967A (en) | 1997-10-17 | 2007-01-25 | A nucleic acid molecule that encodes a homologue of a toll-like receptor and a chimeric molecule that includes it |
IL221367A IL221367A (en) | 1997-10-17 | 2012-08-09 | Isolated nucleic acid encoding a toll-like homologous protein and a toll-like homologous protein preparation process |
Family Applications After (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL135345A IL135345A (en) | 1997-10-17 | 2000-03-29 | Humane TOLL homologues |
IL180967A IL180967A (en) | 1997-10-17 | 2007-01-25 | A nucleic acid molecule that encodes a homologue of a toll-like receptor and a chimeric molecule that includes it |
IL221367A IL221367A (en) | 1997-10-17 | 2012-08-09 | Isolated nucleic acid encoding a toll-like homologous protein and a toll-like homologous protein preparation process |
Country Status (11)
Country | Link |
---|---|
EP (3) | EP1025227B1 (fr) |
JP (3) | JP4319348B2 (fr) |
AT (3) | ATE314471T1 (fr) |
AU (1) | AU1070399A (fr) |
CA (1) | CA2305385C (fr) |
DE (3) | DE69841607D1 (fr) |
DK (3) | DK1025227T3 (fr) |
ES (2) | ES2343210T3 (fr) |
IL (4) | IL135345A0 (fr) |
PT (2) | PT1650219E (fr) |
WO (1) | WO1999020756A2 (fr) |
Families Citing this family (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7696327B1 (en) | 1997-10-17 | 2010-04-13 | Genentech, Inc. | Antibodies to human Toll homologues |
US20030032090A1 (en) | 1997-05-07 | 2003-02-13 | Schering Corporation, A New Jersey Corporation | Human receptor proteins; related reagents and methods |
AU2001264889B2 (en) * | 1997-05-07 | 2006-06-29 | Schering Corporation | Human receptor proteins; related reagents and methods |
WO2001090151A2 (fr) * | 2000-05-25 | 2001-11-29 | Schering Corporation | Proteines receptrices humaines, reactifs et methodes associes |
EP1798288B1 (fr) * | 1997-05-07 | 2009-09-16 | Schering Corporation | Récepteurs protéiques humains du type Toll, réactifs connexés et techniques afférentes |
US6303321B1 (en) | 1999-02-11 | 2001-10-16 | North Shore-Long Island Jewish Research Institute | Methods for diagnosing sepsis |
CA2419894A1 (fr) | 2000-09-15 | 2002-03-21 | Coley Pharmaceutical Gmbh | Procede de criblage a haut rendement d'immuno-agoniste/antagoniste base sur cpg |
US7220723B2 (en) | 2001-05-15 | 2007-05-22 | The Feinstein Institute For Medical Research | Inhibitors of the interaction between HMGB polypeptides and toll-like receptor 2 as anti-inflammatory agents |
US7304034B2 (en) | 2001-05-15 | 2007-12-04 | The Feinstein Institute For Medical Research | Use of HMGB fragments as anti-inflammatory agents |
EP1293566A1 (fr) * | 2001-09-17 | 2003-03-19 | Societe Des Produits Nestle S.A. | Un récepteur soluble de type toll |
KR20040099418A (ko) * | 2002-04-08 | 2004-11-26 | 다케다 야쿠힌 고교 가부시키가이샤 | 중증 패혈증 예방 치료제 |
DE60336341D1 (de) | 2002-05-04 | 2011-04-21 | Acorda Therapeutics Inc | Zusammensetzungen und verfahren zur förderung des neuronalen wachstums |
BR0316223A (pt) | 2002-11-12 | 2005-10-04 | Becton Dickinson Co | Métodos para determinar o estado de sepsia, para prognosticar o começo de sepsia e para diagnosticar a sìndrome de resposta inflamatória sistêmica em um indivìduo |
EP1567863A4 (fr) * | 2002-11-22 | 2007-10-03 | Nuvelo Inc | Procedes de therapie et de diagnostic |
EP1631687A2 (fr) * | 2003-04-22 | 2006-03-08 | Coley Pharmaceutical GmbH | Procedes et produits pour identifier et evaluer des ligands des tlr |
US8906363B2 (en) * | 2003-05-16 | 2014-12-09 | Acorda Therapeutics, Inc. | Fusion proteins for the treatment of CNS |
US7959914B2 (en) | 2003-05-16 | 2011-06-14 | Acorda Therapeutics, Inc. | Methods of reducing extravasation of inflammatory cells |
US7696169B2 (en) | 2003-06-06 | 2010-04-13 | The Feinstein Institute For Medical Research | Inhibitors of the interaction between HMGB polypeptides and toll-like receptor 2 as anti-inflammatory agents |
JP4562123B2 (ja) * | 2003-06-17 | 2010-10-13 | 明治乳業株式会社 | Toll様レセプター強制発現細胞の利用 |
US8163506B2 (en) | 2003-06-17 | 2012-04-24 | Meiji Co., Ltd. | Use of toll-like receptor-expressing cells |
AU2004272607B2 (en) | 2003-09-11 | 2008-11-06 | Cornerstone Therapeutics Inc. | Monoclonal antibodies against HMGB1 |
AU2005244933B2 (en) | 2004-05-18 | 2011-08-04 | Acorda Therapeutics, Inc. | Methods of purifying chondroitinase and stable formulations thereof |
JP2008500064A (ja) * | 2004-05-21 | 2008-01-10 | ザ ユーエービー リサーチ ファウンデーション | 可変性リンパ球受容体、その関連ポリペプチドおよび核酸、ならびにその使用 |
EP1869463A4 (fr) | 2005-04-15 | 2010-05-05 | Becton Dickinson Co | Diagnostic d'une sepsie |
ES2393748T3 (es) | 2005-09-26 | 2012-12-27 | Acorda Therapeutics, Inc. | Composiciones y métodos de uso de condroitinasa ABCI mutantes |
WO2007051164A2 (fr) | 2005-10-27 | 2007-05-03 | Centocor, Inc. | Modulateurs du recepteur de type toll 3, et leurs procedes et utilisations |
JP2009536022A (ja) * | 2006-04-19 | 2009-10-08 | ジェネンテック・インコーポレーテッド | 新規の遺伝子破壊、それに関連する組成物および方法 |
EP2079835B1 (fr) | 2006-10-10 | 2014-03-26 | Acorda Therapeutics, Inc. | Compositions et procédés d'utilisation de mutants des chondroïtinases abci |
WO2009123737A2 (fr) | 2008-04-03 | 2009-10-08 | Becton, Dickinson And Company | Détection avancée d'une sepsie |
TWI481401B (zh) | 2010-01-27 | 2015-04-21 | Takeda Pharmaceutical | 藥劑 |
CN117534753B (zh) * | 2023-12-07 | 2024-05-10 | 北京博奥森生物技术有限公司 | 一种诱导高性能NF-κB多克隆抗体多肽及其应用 |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
US4676980A (en) | 1985-09-23 | 1987-06-30 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Target specific cross-linked heteroantibodies |
CA1338518C (fr) | 1987-09-23 | 1996-08-13 | Joyce M. Zarling | Heteroconjugues d'anticorps pour tuer les cellules infectees par le vih |
GB8823869D0 (en) | 1988-10-12 | 1988-11-16 | Medical Res Council | Production of antibodies |
AU641673B2 (en) | 1989-06-29 | 1993-09-30 | Medarex, Inc. | Bispecific reagents for aids therapy |
US5661016A (en) | 1990-08-29 | 1997-08-26 | Genpharm International Inc. | Transgenic non-human animals capable of producing heterologous antibodies of various isotypes |
ES2108048T3 (es) | 1990-08-29 | 1997-12-16 | Genpharm Int | Produccion y utilizacion de animales inferiores transgenicos capaces de producir anticuerpos heterologos. |
US5625126A (en) | 1990-08-29 | 1997-04-29 | Genpharm International, Inc. | Transgenic non-human animals for producing heterologous antibodies |
US5633425A (en) | 1990-08-29 | 1997-05-27 | Genpharm International, Inc. | Transgenic non-human animals capable of producing heterologous antibodies |
US5545806A (en) | 1990-08-29 | 1996-08-13 | Genpharm International, Inc. | Ransgenic non-human animals for producing heterologous antibodies |
WO1992020373A1 (fr) | 1991-05-14 | 1992-11-26 | Repligen Corporation | Anticorps d'heteroconjugues pour le traitement des infections a l'hiv |
WO1993008829A1 (fr) | 1991-11-04 | 1993-05-13 | The Regents Of The University Of California | Compositions induisant la destruction de cellules infectees par l'hiv |
EP1798288B1 (fr) * | 1997-05-07 | 2009-09-16 | Schering Corporation | Récepteurs protéiques humains du type Toll, réactifs connexés et techniques afférentes |
ES2263865T3 (es) * | 1998-03-25 | 2006-12-16 | Genentech, Inc. | Homologo humano de neurotrimina. |
-
1998
- 1998-10-07 AT AT98953294T patent/ATE314471T1/de not_active IP Right Cessation
- 1998-10-07 DK DK98953294T patent/DK1025227T3/da active
- 1998-10-07 PT PT05023238T patent/PT1650219E/pt unknown
- 1998-10-07 EP EP98953294A patent/EP1025227B1/fr not_active Revoked
- 1998-10-07 WO PCT/US1998/021141 patent/WO1999020756A2/fr active Application Filing
- 1998-10-07 ES ES07020354T patent/ES2343210T3/es not_active Expired - Lifetime
- 1998-10-07 DK DK05023238T patent/DK1650219T3/da active
- 1998-10-07 DE DE69841607T patent/DE69841607D1/de not_active Expired - Lifetime
- 1998-10-07 ES ES05023238T patent/ES2298905T3/es not_active Expired - Lifetime
- 1998-10-07 PT PT07020354T patent/PT1887014E/pt unknown
- 1998-10-07 AT AT07020354T patent/ATE463502T1/de active
- 1998-10-07 DK DK07020354.2T patent/DK1887014T3/da active
- 1998-10-07 EP EP05023238A patent/EP1650219B1/fr not_active Expired - Lifetime
- 1998-10-07 EP EP07020354A patent/EP1887014B1/fr not_active Expired - Lifetime
- 1998-10-07 JP JP2000517077A patent/JP4319348B2/ja not_active Expired - Lifetime
- 1998-10-07 DE DE69838888T patent/DE69838888T2/de not_active Expired - Lifetime
- 1998-10-07 AT AT05023238T patent/ATE381574T1/de active
- 1998-10-07 AU AU10703/99A patent/AU1070399A/en not_active Abandoned
- 1998-10-07 IL IL13534598A patent/IL135345A0/xx active IP Right Grant
- 1998-10-07 DE DE69833014T patent/DE69833014T2/de not_active Revoked
- 1998-10-07 CA CA2305385A patent/CA2305385C/fr not_active Expired - Lifetime
-
2000
- 2000-03-29 IL IL135345A patent/IL135345A/en not_active IP Right Cessation
-
2007
- 2007-01-25 IL IL180967A patent/IL180967A/en not_active IP Right Cessation
-
2008
- 2008-12-24 JP JP2008328570A patent/JP5027105B2/ja not_active Expired - Lifetime
-
2012
- 2012-01-31 JP JP2012017737A patent/JP5425244B2/ja not_active Expired - Lifetime
- 2012-08-09 IL IL221367A patent/IL221367A/en not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL180967A0 (en) | Human toll homologues | |
IL131016A0 (en) | Selection of proteins using rna-protein fusions | |
ATE329028T1 (de) | Nl3 tie rezeptortyrosinekinase ligandhomologe | |
EP0832973A3 (fr) | Protéine de liaison de GTP | |
DE69839444D1 (de) | Smad 6 und dessen anwendungen | |
IL161016A (en) | Polypeptides capable of ang-2 binding | |
EP1517144A3 (fr) | Procédé d'identification d'anticorps se liant au récepteur vanilloide humain et modifiant l'activité de ce dernier | |
EP1246686A4 (fr) | Identification rapide de proteines a l'aide de melanges d'anticorps | |
MXPA01008605A (es) | Proteina de enlace del antigeno goodpasture. | |
GB9816514D0 (en) | Novel method | |
GB2332906A8 (en) | Nucleic acids encoding TTX-resistant Na channel proteins | |
EP0816498A3 (fr) | Récepteur pour acide aminé excitateur et acides nucléiques liés | |
ES2178203T3 (es) | Metodos y reactivos para modular la apoptosis. | |
DE59712604D1 (de) | Mittel zur identifizierung und therapie metastasierender tumore | |
WO2000034294A3 (fr) | Homologue recepteur du facteur de necrose tumorale (trh1) | |
WO1998002557A3 (fr) | Fnt-alpha convertase mammalienne | |
WO2001021794A3 (fr) | Polypeptides associant smad | |
MX9701904A (es) | Proteinas de enlace de pka novedosas y usos de las mismas. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FF | Patent granted | ||
KB | Patent renewed | ||
KB | Patent renewed | ||
KB | Patent renewed |